Formulation and preclinical studies with a trivalent rotavirus P2-VP8 subunit vaccine

Formulation and preclinical studies with a trivalent rotavirus P2-VP8 subunit vaccine

More effective rotavirus vaccines are essential for preventing extensive diarrheal morbidity and mortality in children under five years of age in low-resource regions. Nonreplicating rotavirus vaccines (NRRV) administered parenterally provide an alternate vaccination method to the current licensed o...

Full description

Bibliographic Details
Main Authors: Kyle Lakatos, David McAdams, Jessica A. White, Dexiang Chen
Format: Article
Language:English
Published: Taylor & Francis Group 2020-08-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
rotavirus
nonreplicating rotavirus vaccine (nrrv)
antigen adsorption
antigen integrity
immunogenicity
Online Access:http://dx.doi.org/10.1080/21645515.2019.1710412

Similar Items

Similar Items